Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Diamondcutter who wrote (7442)	4/25/1998 12:07:00 PM
From: ChinuSFO	Respond to of 23519

A local newspaper in Silicon Valley is reporting that rumors abound about the impending buyout of Vivus by Johnson & Johnson. Anybody heard anything of that sort. The likely scenario is that FDA approves bulk manufacturing of MUSE, the stock soars. Else if FDA does not, then the clout of a large company such as J&J (if they buy them out) will be used to get the required FDA approval at about the same time the initial optimism on Viagara wears out, say in about 6 to 8 months